After the treatment, a reduction in hypertension, hypernatremia, and alkalosis was also reported, and this was considered a result of systemic kallikrein inhibition due to ointment use, as the patient did not receive any other systemic therapy (34). Here, KLK4 is linked to Hypernatremia.